Google Glass-Based Startup Raises $17 Million in Funding

Grow Your Business, Not Your Inbox

Stay informed and join our daily newsletter now!
Will be used in accordance with our Privacy Policy
Google Glass-Based Startup Raises $17 Million in Funding
Image credit: Boston Globe | Getty Images
1 min read
This story originally appeared on Reuters

Augmedix Inc., a startup that uses Alphabet Inc.'s Google Glass to provide documentation services to doctors and other healthcare workers, said on Monday it had closed a $17 million funding round led by investment firm Redmile Group.

Augmedix's employees transcribe doctors' notes and update patients' electronic medical record through Google Glass.

The San Francisco company, which has raised $40 million so far, also said it had received investments from five U.S. healthcare networks, including Sutter Health and Dignity Health, which together have more than 100,000 healthcare workers.

Augmedix, with 400 employees, said it serves doctors in nearly all 50 U.S. states.

Funds raised will be used to build up the service to serve more health systems and private clinics, the company said.

Augmedix is one of 10 partners authorized by Alphabet to deliver enterprise services through Google Glass.

(Reporting by Kshitiz Goliya in Bengaluru; Editing by Ted Kerr)

More from Entrepreneur

Get heaping discounts to books you love delivered straight to your inbox. We’ll feature a different book each week and share exclusive deals you won’t find anywhere else.
Jumpstart Your Business. Entrepreneur Insider is your all-access pass to the skills, experts, and network you need to get your business off the ground—or take it to the next level.
Create your business plan in half the time with twice the impact using Entrepreneur's BIZ PLANNING PLUS powered by LivePlan. Try risk free for 60 days.

Latest on Entrepreneur

Entrepreneur Media, Inc. values your privacy. In order to understand how people use our site generally, and to create more valuable experiences for you, we may collect data about your use of this site (both directly and through our partners). By continuing to use this site, you are agreeing to the use of that data. For more information on our data policies, please visit our Privacy Policy.